Conflicts of interest: Michael Kamm has served as a consultant and speaker to Abbott, Schering-Plough, and UCB. Stephen Hanauer has received grants for clinical research and educational activities from, and has served as an advisor or consultant to, Shire, P&G Pharmaceuticals, Salix, Abbott, Centocor, UCB, and Prometheus.
Article first published online: 18 FEB 2011
Copyright © 2011 Crohn's & Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 17, Issue 11, pages 2366–2391, November 2011
How to Cite
Kamm, M. A., Ng, S. C., De Cruz, P., Allen, P. and Hanauer, S. B. (2011), Practical application of anti-TNF therapy for luminal Crohn's disease. Inflamm Bowel Dis, 17: 2366–2391. doi: 10.1002/ibd.21655
Author contributions: M.A. Kamm (study concept and design; study supervision, critical revision of article), S.C. Ng (Literature search, drafting of article, revision of article), P. D'Cruz (literature search, drafting of article), PAllen (Literature search, drafting of article), S Hanauer (critical revision of article).
- Issue published online: 10 OCT 2011
- Article first published online: 18 FEB 2011
- Manuscript Accepted: 31 DEC 2010
- Manuscript Received: 17 DEC 2010